A Clinical Evaluation of Two Contact Lenses Used With Three Care Systems
NCT ID: NCT04195581
Last Updated: 2021-06-11
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
33 participants
INTERVENTIONAL
2019-09-16
2020-05-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Performance of Existing Wearers of Enfilcon A Following a Refit With Fanfilcon A Lenses for 4 Weeks
NCT02670473
Multi-Centre Clinical Evaluation of Two Reusable Soft Contact Lenses
NCT02815735
A Clinical Comparison of Two Daily Disposable Soft Contact Lenses
NCT04005885
Bilateral Dispensing Study of Fanfilcon A Toric Versus Enfilcon A Toric Lenses
NCT02423109
Evaluation of the CooperVision, Inc. Fanfilcon A and Enfilcon A Daily Wear Contact Lenses When Used for Frequent Replacement for up to One (1) Month of Daily Wear
NCT02555722
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
comfilcon A with Hy-Care Multi-purpose solution
Subjects were randomized to wear each lens and solution combination for a month.
comfilcon A
Subjects were randomized to wear each lens and solution combination for a month.
comfilcon A with All in One Light Multi-purpose solution
Subjects were randomized to wear each lens and solution combination for a month.
comfilcon A
Subjects were randomized to wear each lens and solution combination for a month.
comfilcon A with Refine One Step Hydrogen Peroxide Solution
Subjects were randomized to wear each lens and solution combination for a month.
comfilcon A
Subjects were randomized to wear each lens and solution combination for a month.
fanfilcon A with Hy-Care Multi-purpose solution
Subjects were randomized to wear each lens and solution combination for a month.
fanfilcon A
Subjects were randomized to wear each lens and solution combination for a month.
fanfilcon A with All in One Light multi-purpose solution
Subjects were randomized to wear each lens and solution combination for a month.
fanfilcon A
Subjects were randomized to wear each lens and solution combination for a month.
fanfilcon A with Refine One Step Hydrogen Peroxide Solution
Subjects were randomized to wear each lens and solution combination for a month.
fanfilcon A
Subjects were randomized to wear each lens and solution combination for a month.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
comfilcon A
Subjects were randomized to wear each lens and solution combination for a month.
fanfilcon A
Subjects were randomized to wear each lens and solution combination for a month.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. They understand their rights as a research subject and are willing and able to sign a Statement of Informed Consent.
3. They are willing and able to follow the protocol.
4. They are an existing wearer of reusable, single vision, spherical soft contact lenses.
5. They have a contact lens spherical prescription between -1.00 to - 6.50D (inclusive)
6. They have a spectacle cylindrical correction of -1.00D or less in each eye.
7. At dispensing, they can attain at least 0.20 logMAR distance high contrast visual acuity in each eye with the study lenses within the available power range.
8. They are willing to comply with the wear schedule (at least five days per week and for at least eight hours per day).
9. They agree not to participate in other clinical research for the duration of the study.
Exclusion Criteria
2. They have a systemic disorder which would normally contra-indicate contact lens wear.
3. They are using any topical medication such as eye drops or ointment.
4. They have had cataract surgery.
5. They have had corneal refractive surgery.
6. They have any corneal distortion resulting from previous hard or rigid lens wear or have keratoconus.
7. They are pregnant or breastfeeding.
8. They have any ocular abnormality which would, in the opinion of the investigator, normally contraindicate contact lens wear.
9. They have any infectious disease which would, in the opinion of the investigator, contraindicate contact lens wear or pose a risk to study personnel; or they have any immunosuppressive disease (e.g. HIV), or a history of anaphylaxis or severe allergic reaction.
10. They have taken part in any other contact lens or care solution clinical trial or research, within two weeks prior to starting this study.
18 Years
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
CooperVision, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Philip Morgan, MCOptom FAAO FBCLA
Role: PRINCIPAL_INVESTIGATOR
Eurolens Research
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The University of Manchester
Manchester, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
C19-658 EX-MKTG-108
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.